ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2017 American Transplant Congress

    Decision Tree Analysis of Renal Transplantation Recipients Outcomes: A Single Center Data Mining in the Big Data Era.

    J. Zhou,1 Y. Shen,2 R. Wang,1 H. Huang,1 J. Wu,1 J. Chen.1

    1Kidney Disease Center, the First Affiliated Hospital, Zhejiang University, Hangzhou, China; 2Department of Epidemiology, College of Medicine, Zhejiang University, Hangzhou, China

    Background This is the era of big data and it may help manage clinical practice better. Decision tree analysis is a useful data mining tool…
  • 2017 American Transplant Congress

    Very Long Term Graft Survival. Forecasts Factors.

    S. Jimenez Alvaro, R. Marcen Letosa, A. Fernandez Rodriguez, S. Elias Treviño, C. Galeano Alvarez, F. Liaño Garcia.

    Nephrology, Hospital Ramon y Cajal, Madrid, Spain

    Introduction: Kidney transplantation is the best treatment for end-stage renal failure. Between 2 and 5% of transplanted grafts are lost each year and only a…
  • 2017 American Transplant Congress

    Simultaneous Pancreas-Kidney Transplantation Can Be Safely Done on Dabigatran Therapy.

    W. Lisik,1 A. Jozwik,1 J. Czerwinski,2 L. Gorski,1 M. Kosieradzki.1

    1Department of General and Transplantation Surgery, The Medical University of Warsaw, Warsaw, Poland; 2Department of Surgical and Transplant Nursing, The Medical University of Warsaw, Warsaw, Poland

    Due to convenient application, novel oral anticoagulants (NOAC), although not registered for renal failure, are an attractive therapeutic option. They are even more tempting in…
  • 2017 American Transplant Congress

    Senescence and Uremia Effects in Circulating T Cells Diverge in TREG Population and Cause T Cell Shift to a Memory Profile.

    G. Freitas,1 M. Fernandes,1 F. Agena,1 O. Jabuul,2 V. Coelho,3 F. Lemos,1 F. Ramos,1 A. Triboni,1 E. David-Neto,1 N. Galante.1

    1Renal Transplantation Service, University of Sao Paulo, Sao Paulo, Brazil; 2Department of Geriatrics, University of Sao Paulo, Sao Paulo, Brazil; 3Laboratory of Immunology, InCor, University of Sao Paulo, Sao Paulo, Brazil

    Elderly kidney transplant recipients(EKtx) have higher malignancies and infections rates, but lower acute rejection incidence. Senescence seems to result in shift to memory profile and…
  • 2017 American Transplant Congress

    High Risk Renal Transplant Recipients on Steroid Free Immunosupression Regimen. Indiana University Experience.

    O. Adebiyi, S. Hussain, D. Mishler, W. Goggins, M. Yaqub, T. Taber, A. Sharfuddin.

    Renal Transplant, Indiana University School of Medicine, Indianapolis, IN

    Background : Immunologic risk often influence the choice immunosuppressive regimen used in renal transplant recipient. Patient with positive flow cytometry crossmatch (FCXM) or presence of…
  • 2017 American Transplant Congress

    A Novel, Dose-Adjusted Tacrolimus Trough Concentration (TTC) Model for Prediction and Variance Estimation.

    J. Kim,1 S. Wilson,1 N. Undre,2 S. Fei,1 R. Kristy,1 J. Schwartz.1

    1Astellas Pharma Global Development, Inc., Northbrook, IL; 2Astellas Pharma Global Development, Inc., Chertsey, United Kingdom

    Given that a high tacrolimus (tac) intrapatient variability (IPV) increases the risk for a poor kidney transplant (tx) outcome, some experts advocate routine IPV monitoring…
  • 2017 American Transplant Congress

    Early Exposure of Everolimus with and without Calcineurin Inhibitors.

    C. Felipe, A. Ferreira, T. Abait, A. Bessa, P. Ruppel, L. Hiramoto, M. Ivani, H. Tedesco, J. Medina- Pestana.

    Nephrology Division, Hospital do Rim, UNIFESP, São Paulo, SP, Brazil

    This study aimed to evaluate the effect of cyclosporine (CSA) or tacrolimus (TAC) on early exposure of everolimus (EVR).A cohort of 306 kidney transplant recipients…
  • 2017 American Transplant Congress

    Everolimus Reduces Carotid Intima-Media Thickness in Renal Transplant Recipients After One Year: Randomized Controlled Trial.

    P. Garcia, H. Takase, H. Nga, M. Contti, J. Hueb, L. Morales-Buenrostro.

    Internal Medicine, Botucatu Medical School - Universidade Estadual Paulista, Botucatu, São Paulo, Brazil

    Cardiovascular disease remains the commonest cause of death in kidney transplant recipients. Although some studies suggest that Mammalian target of rapamycin (mTOR) inhibitors may reduce…
  • 2017 American Transplant Congress

    Strategies to Promote Pediatric Kidney Transplant Program in China – A Coming Opportunity with Development of Pediatric Deceased Donation.

    L. Liu,1 H. Wang,2 J. Ding,3 B. Shi,4 X. Zhong,3 W. Jiang,2 L. Chen,4 H. Zhang,1 C. Wang.1

    1Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; 2China Organ Transplant Response System Research Center, Shenzhen, China; 3Department of Pediatrics, Peking University First Hospital, Beijing, China; 4Data Center of Chinese Scientic Registry of Kidney Transplantation, Beijing, China

    Introduction This article demonstrates the opportunity and challenges of current pediatric kidney transplant program in China, based on the analysis study of the national registry…
  • 2017 American Transplant Congress

    Donor and Recipient Factors Important in Determining the Estimated GFR Difference Between Living Donor and Recipient Pairs Six Months After Transplant.

    D. Keith.

    Medicine, Division of Nephrology, Sacred Heart Hospital, Pensacola, FL

    Analysis of the relationship between living donor and recipient estimated GFR (eGFR) six months after transplant revealed that in the first half of the last…
  • « Previous Page
  • 1
  • …
  • 384
  • 385
  • 386
  • 387
  • 388
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences